|
Age, years (mean ± SD)
|
65.6 ± 10.8
|
65.3 ± 10.9
|
66.5 ± 10.3
|
0.645
|
|
Male, n (%)
|
114 (73.1%)
|
93 (74.4%)
|
21 (67.7%)
|
0.500
|
|
Underlying diseasea
|
|
Malignancy
|
126 (80.8%)
|
101 (80.8%)
|
25 (80.6%)
|
1.000
|
|
Hepatocellular carcinoma
|
49 (31.4%)
|
43 (34.4%)
|
6 (19.4%)
|
−
|
|
Pancreatic cancer
|
24 (15.4%)
|
20 (16.0%)
|
4 (12.9%)
|
−
|
|
Cholangiocarcinoma
|
11 (7.1%)
|
5 (4.0%)
|
6 (19.4%)
|
−
|
|
Other cancers
|
42 (26.9%)
|
33 (26.4%)
|
9 (29.0%)
|
−
|
|
Diabetes mellitus
|
40 (25.6%)
|
33 (26.4%)
|
7 (22.6%)
|
0.819
|
|
Chronic hepatitis/liver cirrhosis
|
21 (13.5%)
|
18 (14.4%)
|
3 (9.7%)
|
0.769
|
|
Chronic kidney disease
|
3 (1.9%)
|
2 (1.6%)
|
1 (3.2%)
|
0.488
|
|
Other diseases
|
30 (19.2%)
|
24 (19.2%)
|
6 (19.4%)
|
1.000
|
|
Immunosuppressive drug use (yes)
|
8 (5.1%)
|
6 (4.8%)
|
2 (6.5%)
|
0.659
|
|
qSOFA score point (mean and range)
|
0.2 (0–3)
|
0.1 (0–1)
|
0.5 (0–3)
|
< 0.001
|
|
Body temperature, °C (mean ± SD)
|
36.8 ± 0.8
|
36.6 ± 0.5
|
37.7 ± 1.1
|
< 0.001
|
|
Skin redness at the insertion site
|
5 (3.2%)
|
0 (0%)
|
5 (16.1%)
|
< 0.001
|
|
Insertion site of CVC
|
|
Jugular
|
148 (94.9%)
|
120 (96.0%)
|
28 (90.3%)
|
0.196
|
|
Femoral
|
3 (1.9%)
|
2 (1.6%)
|
1 (3.2%)
|
0.488
|
|
Peripherally inserted CVC
|
5 (3.2%)
|
3 (2.4%)
|
2 (6.5%)
|
0.259
|
|
Number of lumen
|
|
3
|
103 (66.0%)
|
84 (67.2%)
|
19 (61.3%)
|
0.533
|
|
2
|
48 (30.8%)
|
38 (30.4%)
|
10 (32.3%)
|
0.831
|
|
1
|
5 (3.2%)
|
3 (2.4%)
|
2 (6.5%)
|
0.259
|
|
Primary purpose for CVC insertion
|
|
Perioperative
|
141 (90.4%)
|
114 (91.2%)
|
27 (87.1%)
|
0.500
|
|
Parenteral nutrition
|
9 (5.8%)
|
6 (4.8%)
|
3 (9.7%)
|
0.383
|
|
Intensive care
|
6 (3.8%)
|
5 (4.0%)
|
1 (3.2%)
|
1.000
|
|
Duration of catheterization, days (mean ± SD)
|
9.5 ± 9.0
|
9.0 ± 8.0
|
11.5 ± 12.2
|
0.600
|
|
Antibiotic use during the catheterization
|
153 (98.1%)
|
123 (98.4%)
|
30 (96.8%)
|
0.488
|
|
Antibiotic use after the removal
|
47 (30.1%)
|
22 (17.6%)
|
25 (80.6%)
|
< 0.001
|
|
Defervescence time from the catheter removal, day (mean ± SD)
|
0.8 ± 2.4
|
0.3 ± 0.6
|
3.4 ± 4.5
|
< 0.001
|
